Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Gotrade News - Pfizer just locked in a licensing deal with Sciwind Biosciences for a type 2 diabetes drug called ecnoglutide, with potential payouts reaching up to $495 million
Use GoodRx only if manufacturer programs are unavailable
Be sure to confirm current rates when enrolling
Looking back, I no longer think addiction researchers and obesity researchers were studying different diseases
This pain type, for example, would be more common after a hamburger and fries or greasy pizza than a salad
RESEARCH USE ONLY This product is intended strictly for laboratory research purposes only
US$ 25.13
US$ 28.11
US$ 26.62
US$ 26.48
US$ 22.89
